Paragonix Technologies

Paragonix Technologies designs and manufactures advanced organ preservation systems and digital logistics platforms for the transplant community. The company specializes in controlled-temperature organ transport devices that maintain donor organs at optimal, non-freezing temperatures during procurement and transport. Product lines include SherpaPak (cardiac preservation), LUNGguard (lung preservation), BAROguard (bariatric organ preservation), LIVERguard (liver preservation), PancreasPak (pancreas preservation), and KidneyVault (kidney preservation). All devices are FDA-cleared and CE-marked. Paragonix also offers the Paragonix App, a HIPAA-compliant digital platform for real-time temperature monitoring, GPS tracking, case coordination, and event logging across transplant teams. The company operates GUARDIAN clinical registries (Heart, Lung, and Liver) representing observational databases tracking post-transplant outcomes; over 35 clinical studies have been published. Services include 24/7 clinical procurement support and case logistics management. The company supports over 180 transplant centers globally and has preserved over 10,000 donor organs. Paragonix is positioned as an integrated solution provider bridging hardware, software, clinical data, and support services to improve organ viability and transplant outcomes.